| Cytomegalovirus |
vMIA (anti-apoptotic) interacts with ANT (not VDAC) and prevents MMP |
Goldmacher et al. (1999); Colberg-Poley et al. (2000) |
| Helicobacter pylori |
N-terminal cleavage product (p34) of vacuolating cytotoxin (Vac A) (pro-apoptotic) translocates to mitochondria and releases cytochrome c in a Bcl-2-inhibitable fashion |
Galmiche et al. (2000) |
| Hepatitis B virus |
HBV-X (pro-apoptotic) translocates to mitochondria, interacting with VDAC-3 |
Rahmani et al. (2000) |
| HIV-1 |
Vpr (pro-apoptotic) interacts with ANT and induces MMP, both in intact cells and in mitochondria in vitro; Tat (pro-apoptotic) translocates to mitochondria |
Jacotot et al. (2000); Macho et al. (1999) |
| HTLV-1 |
p13II protein (pro-apoptotic) interacts with mitochondria |
Ciminale et al. (1999) |
| Myxoma virus |
M11L (anti-apoptotic) translocates to mitochondria and prevents MMP |
Everett et al. (2000) |
| Neisseria meningitidis |
porin B (pro-apoptotic) translocates to mitochondria; porin B causes isolated mitochondria to release cytochrome c and to swell |
Muller et al. (2000) |
| Neisseria gonorrhoeae |
porin B (anti-apoptotic) translocates to mitochondria, where it interacts with VDAC; porin B prevents MMP |
Massari et al. (2000) |
